Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 138

1.

Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer.

Glöckner SC, Dhir M, Yi JM, McGarvey KE, Van Neste L, Louwagie J, Chan TA, Kleeberger W, de Bruïne AP, Smits KM, Khalid-de Bakker CA, Jonkers DM, Stockbrügger RW, Meijer GA, Oort FA, Iacobuzio-Donahue C, Bierau K, Herman JG, Baylin SB, Van Engeland M, Schuebel KE, Ahuja N.

Cancer Res. 2009 Jun 1;69(11):4691-9. doi: 10.1158/0008-5472.CAN-08-0142. Epub 2009 May 12.

PMID:
19435926
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.

Melotte V, Lentjes MH, van den Bosch SM, Hellebrekers DM, de Hoon JP, Wouters KA, Daenen KL, Partouns-Hendriks IE, Stessels F, Louwagie J, Smits KM, Weijenberg MP, Sanduleanu S, Khalid-de Bakker CA, Oort FA, Meijer GA, Jonkers DM, Herman JG, de Bruïne AP, van Engeland M.

J Natl Cancer Inst. 2009 Jul 1;101(13):916-27. doi: 10.1093/jnci/djp131. Epub 2009 Jun 17.

PMID:
19535783
[PubMed - indexed for MEDLINE]
Free Article
3.

Detection of methylated tissue factor pathway inhibitor 2 and human long DNA in fecal samples of patients with colorectal cancer in China.

Zhang J, Yang S, Xie Y, Chen X, Zhao Y, He D, Li J.

Cancer Epidemiol. 2012 Feb;36(1):73-7. doi: 10.1016/j.canep.2011.04.006. Epub 2011 May 28.

PMID:
21621497
[PubMed - indexed for MEDLINE]
4.

Detection of TFPI2 methylation in the serum of colorectal cancer patients.

Hibi K, Goto T, Shirahata A, Saito M, Kigawa G, Nemoto H, Sanada Y.

Cancer Lett. 2011 Dec 1;311(1):96-100. doi: 10.1016/j.canlet.2011.07.006. Epub 2011 Jul 22.

PMID:
21820798
[PubMed - indexed for MEDLINE]
5.

Methylation of TFPI2 gene is frequently detected in advanced well-differentiated colorectal cancer.

Hibi K, Goto T, Kitamura YH, Yokomizo K, Sakuraba K, Shirahata A, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y.

Anticancer Res. 2010 Apr;30(4):1205-7.

PMID:
20530429
[PubMed - indexed for MEDLINE]
6.

DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT.

Bosch LJ, Oort FA, Neerincx M, Khalid-de Bakker CA, Terhaar sive Droste JS, Melotte V, Jonkers DM, Masclee AA, Mongera S, Grooteclaes M, Louwagie J, van Criekinge W, Coupé VM, Mulder CJ, van Engeland M, Carvalho B, Meijer GA.

Cancer Prev Res (Phila). 2012 Mar;5(3):464-72. doi: 10.1158/1940-6207.CAPR-11-0315. Epub 2011 Dec 1.

PMID:
22135045
[PubMed - indexed for MEDLINE]
7.

Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer.

Lenhard K, Bommer GT, Asutay S, Schauer R, Brabletz T, Göke B, Lamerz R, Kolligs FT.

Clin Gastroenterol Hepatol. 2005 Feb;3(2):142-9.

PMID:
15704048
[PubMed - indexed for MEDLINE]
8.

Novel methylation panel for the early detection of colorectal tumors in stool DNA.

Azuara D, Rodriguez-Moranta F, de Oca J, Soriano-Izquierdo A, Mora J, Guardiola J, Biondo S, Blanco I, Peinado MA, Moreno V, Esteller M, Capellá G.

Clin Colorectal Cancer. 2010 Jul;9(3):168-76. doi: 10.3816/CCC.2010.n.023.

PMID:
20643622
[PubMed - indexed for MEDLINE]
9.

SFRP2 methylation in fecal DNA--a marker for colorectal polyps.

Oberwalder M, Zitt M, Wöntner C, Fiegl H, Goebel G, Zitt M, Köhle O, Mühlmann G, Ofner D, Margreiter R, Müller HM.

Int J Colorectal Dis. 2008 Jan;23(1):15-9. Epub 2007 Jul 17.

PMID:
17639423
[PubMed - indexed for MEDLINE]
10.

Comparative analysis of PCR-based biomarker assay methods for colorectal polyp detection from fecal DNA.

Ausch C, Kim YH, Tsuchiya KD, Dzieciatkowski S, Washington MK, Paraskeva C, Radich J, Grady WM.

Clin Chem. 2009 Aug;55(8):1559-63. doi: 10.1373/clinchem.2008.122937. Epub 2009 Jun 18.

PMID:
19541867
[PubMed - indexed for MEDLINE]
Free Article
11.

Detection of TFPI2 methylation in the serum of gastric cancer patients.

Hibi K, Goto T, Shirahata A, Saito M, Kigawa G, Nemoto H, Sanada Y.

Anticancer Res. 2011 Nov;31(11):3835-8.

PMID:
22110206
[PubMed - indexed for MEDLINE]
12.

Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions.

Huang Z, Li L, Wang J.

Dig Dis Sci. 2007 Sep;52(9):2287-91. Epub 2007 Apr 5.

PMID:
17410438
[PubMed - indexed for MEDLINE]
13.

Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.

Lee S, Oh T, Chung H, Rha S, Kim C, Moon Y, Hoehn BD, Jeong D, Lee S, Kim N, Park C, Yoo M, An S.

Int J Oncol. 2012 Mar;40(3):889-98. doi: 10.3892/ijo.2011.1245. Epub 2011 Oct 25.

PMID:
22038115
[PubMed - indexed for MEDLINE]
14.

GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.

Hellebrekers DM, Lentjes MH, van den Bosch SM, Melotte V, Wouters KA, Daenen KL, Smits KM, Akiyama Y, Yuasa Y, Sanduleanu S, Khalid-de Bakker CA, Jonkers D, Weijenberg MP, Louwagie J, van Criekinge W, Carvalho B, Meijer GA, Baylin SB, Herman JG, de Bruïne AP, van Engeland M.

Clin Cancer Res. 2009 Jun 15;15(12):3990-7. doi: 10.1158/1078-0432.CCR-09-0055. Epub 2009 Jun 9.

PMID:
19509152
[PubMed - indexed for MEDLINE]
Free Article
15.

Stool-based DNA testing, a new noninvasive method for colorectal cancer screening, the first report from Iran.

Abbaszadegan MR, Tavasoli A, Velayati A, Sima HR, Vosooghinia H, Farzadnia M, Asadzedeh H, Gholamin M, Dadkhah E, Aarabi A.

World J Gastroenterol. 2007 Mar 14;13(10):1528-33.

PMID:
17461444
[PubMed - indexed for MEDLINE]
Free Article
16.

Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detection.

Bosch LJ, Mongera S, Terhaar Sive Droste JS, Oort FA, van Turenhout ST, Penning MT, Louwagie J, Mulder CJ, van Engeland M, Carvalho B, Meijer GA.

Cell Oncol (Dordr). 2012 Aug;35(4):309-15. doi: 10.1007/s13402-012-0092-6. Epub 2012 Jul 21.

PMID:
22821210
[PubMed - indexed for MEDLINE]
17.

Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning.

Mori Y, Olaru AV, Cheng Y, Agarwal R, Yang J, Luvsanjav D, Yu W, Selaru FM, Hutfless S, Lazarev M, Kwon JH, Brant SR, Marohn MR, Hutcheon DF, Duncan MD, Goel A, Meltzer SJ.

Endocr Relat Cancer. 2011 Jul 4;18(4):465-78. doi: 10.1530/ERC-11-0083. Print 2011 Aug.

PMID:
21636702
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: a preliminary report in Korean patients.

Chang E, Park DI, Kim YJ, Kim BK, Park JH, Kim HJ, Cho YK, Sohn CI, Jeon WK, Kim BI, Kim HD, Kim DH, Kim YH.

Hepatogastroenterology. 2010 Jul-Aug;57(101):720-7.

PMID:
21033217
[PubMed - indexed for MEDLINE]
19.

Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia in Korean patients.

Baek YH, Chang E, Kim YJ, Kim BK, Sohn JH, Park DI.

Dis Colon Rectum. 2009 Aug;52(8):1452-9; discussion 1459-63. doi: 10.1007/DCR.0b013e3181a79533.

PMID:
19617759
[PubMed - indexed for MEDLINE]
20.

Frequent epigenetic silencing of PCDH10 by methylation in human colorectal cancer.

Zhong X, Zhu Y, Mao J, Zhang J, Zheng S.

J Cancer Res Clin Oncol. 2013 Mar;139(3):485-90. doi: 10.1007/s00432-012-1353-5. Epub 2012 Nov 22.

PMID:
23180019
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk